Skip to content
OpenCapital
Get started

Warby Parker WRBY Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
——

Other financials

Income statement

See full
Revenue$242.4M+8.3%
Gross profit$131.0M+4.0%
Operating income$1.7M-32.5%
Net income$3.2M-8.5%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$288.2M+8.7%
Total debt$237.6M+6.2%
Total equity$375.8M+6.1%
Total assets$736.4M+7.9%

Cash flow

See full
Operating cash flow$24.5M-16.5%
CapEx$16.1M-0.1%
Free cash flow$8.4M-36.6%

Valuation

See full
Market cap$3.15B+17.1%

Profitability

See full
Gross margin53.4%-1.8pp
Operating margin-0.7%-0.3pp
Net margin0.1%0.0pp
FCF margin4.5%-0.8pp

Returns & leverage

See full
Return on equity0.2%+0.1pp
Debt / equity0.6×0.0×
Current ratio2.3×-0.4×

Where this comes from

Reported directly by Warby Parker in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Warby Parker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Warby Parker's share based compensation arrangement by share based payment award options exercisable number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Warby Parker's share based compensation arrangement by share based payment award options exercisable number?
Warby Parker (WRBY) reported share based compensation arrangement by share based payment award options exercisable number of $1.64M in Q1 2026.
How has Warby Parker's share based compensation arrangement by share based payment award options exercisable number changed year-over-year?
Warby Parker's share based compensation arrangement by share based payment award options exercisable number decreased by 2.0% year-over-year, from $1.67M to $1.64M.
What is the long-term trend for Warby Parker's share based compensation arrangement by share based payment award options exercisable number?
Over 4 years (2021 to 2025), Warby Parker's share based compensation arrangement by share based payment award options exercisable number has grown at a -18.0% compound annual growth rate (CAGR), from $3.62M to $1.64M.